相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of Zinc Alpha2 Glycoprotein on Lipid Metabolism of Liver in High-Fat Diet-Induced Obese Mice
Guoqiang Fan et al.
HORMONE AND METABOLIC RESEARCH (2017)
Increased Dynamics of Tricarboxylic Acid Cycle and Glutamate Synthesis in Obese Adipose Tissue IN VIVO METABOLIC TURNOVER ANALYSIS
Hirofumi Nagao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
Liang Xu et al.
EBIOMEDICINE (2017)
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)
Mikhail Kosiborod et al.
CIRCULATION (2017)
β-Hydroxybutyrate elevation as a compensatory response against oxidative stress in cardiomyocytes
Manabu Nagao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
CV Protection in the EMPA-REG OUTCOME Trial: A Thrifty Substrate Hypothesis
Ele Ferrannini et al.
DIABETES CARE (2016)
Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis
F. Zaccardi et al.
DIABETES OBESITY & METABOLISM (2016)
Tofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male Mice
Atsushi Obata et al.
ENDOCRINOLOGY (2016)
Metabolic Regulation of Gene Expression by Histone Lysine β-Hydroxybutyrylation
Zhongyu Xie et al.
MOLECULAR CELL (2016)
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Increases Circulating Zinc-A2-Glycoprotein Levels in Patients with Type 2 Diabetes
Xin Liao et al.
SCIENTIFIC REPORTS (2016)
The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice
Yasushi Honda et al.
PLOS ONE (2016)
Impact of Reduced ATGL-Mediated Adipocyte Lipolysis on Obesity-Associated Insulin Resistance and Inflammation in Male Mice
Gabriele Schoiswohl et al.
ENDOCRINOLOGY (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance
A. Young Kim et al.
NATURE COMMUNICATIONS (2015)
Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia
David G. Cotter et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Coupling of lipolysis and de novo lipogenesis in brown, beige, and white adipose tissues during chronic β3-adrenergic receptor activation
Emilio P. Mottillo et al.
JOURNAL OF LIPID RESEARCH (2014)
Ketone bodies as signaling metabolites
John C. Newman et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Tofogliflozin, a sodium/glucose cotransporter 2 inhibitor, attenuates body weight gain and fat accumulation in diabetic and obese animal models
M. Suzuki et al.
NUTRITION & DIABETES (2014)
Ketone body metabolism and cardiovascular disease
David G. Cotter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
Tadahiro Shimazu et al.
SCIENCE (2013)
Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial
Michael Roden et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus
Volker Vallon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Anti-inflammatory and anti-atherogenic properties of adiponectin
Koji Ohashi et al.
BIOCHIMIE (2012)
Weight Loss Induced by Chronic Dapagliflozin Treatment Is Attenuated by Compensatory Hyperphagia in Diet-Induced Obese (DIO) Rats
James J. Devenny et al.
OBESITY (2012)
Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes
Christine Clar et al.
BMJ OPEN (2012)
Identification of a novel distal enhancer in human adiponectin gene
Katsumori Segawa et al.
JOURNAL OF ENDOCRINOLOGY (2009)
Modifications of Histone H3 at Lysine 9 on the Adiponectin Gene in 3T3-L1 Adipocytes
Naoko Sakurai et al.
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2009)
Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models
Yoshikazu Fujimori et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level
Kenji Katsuno et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The metabolic syndrome and adipocytokines
Yuji Matsuzawa
FEBS LETTERS (2006)
Anaplerotic roles of pyruvate carboxylase in mammalian tissues
S Jitrapakdee et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Chromatin immunoprecipitation and microarray-based analysis of protein location
Tong Ihn Lee et al.
NATURE PROTOCOLS (2006)
JNK and tumor necrosis factor-α mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes
MTA Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors
M Iwaki et al.
DIABETES (2003)
分享论文
